Nanoform targets cost leadership for CESS platform as it scales commercial GMP output
Nanoform (NANOFH.HE) aims to make its CESS technology a cost leader against spray-dried amorphous solid dispersions by expanding clinical and commercial GMP CESS capacity in Helsinki for multi-ton annual production. The company plans to lower costs through higher yields, reduced excipient use, simplified processing, an